ANDREA MCCLELLAN: Open Payments
NPI 1366217531 · CONNERSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 32 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $248 |
| Alkermes, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Corium, LLC | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, ARISTADA, FANAPT, AUSTEDO XR, CAPLYTA, Azstarys, COBENFY, ERZOFRI EXTENDED-RELEASE.
Industry payments across IN — which companies pay providers there.
